CUL4B and colorectal carcinoma: Through in vitro and in vivo experiments, we revealed that CUL4B influences the occurrence of EMT and regulates the progression of platinum‐based chemotherapeutic resistance in CRC and is of great significance to the survival and prognosis of these patients.